Use of neurotransmitter precursors for treatment of depression

Alternative Medicine Review

Volumn 5, Issue 1, 2000, Pages 64-71

  Meyers, Stephen ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXYTRYPTOPHAN; PHENYLALANINE; TRYPTOPHAN; TYROSINE;

DEPRESSION; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; REVIEW;

5-HYDROXYTRYPTOPHAN; DEPRESSION; HUMANS; PHENYLALANINE; TRYPTOPHAN; TYROSINE;

EID: 0034008099     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Garlow S, Musselman D, Nemeroff C. The neurochemistry of mood disorders: clinical studies. In: Charney D, Nestler E, Bunney B, eds. The Neurobiological Foundation of Mental Illness. New York: Oxford University Press; 1999.
2. Growdon JH. Neurotransmitter precursors in the diet: their use in the treatment of brain diseases. In: Wurtman RJ, Wurtman JJ, eds. Nutrition and the Brain Series. Vol. 3. Berkeley, CA;Raven Press: 1979.
3. Young SN, Gauthier AM. Effect of tryptophan administration on tryptophan, 5-hydroxyindóleacetic acid and indoleacetic acid in human lumbar and cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1981;44:323-327.
4. Trulson ME; Jacobs BL. Dose-response relationships between systemically administered L-tryptophan or L-5-hydroxytryptophan and raphe unit activity in the rat. Neuropharmacology 1976;15:339-344.
5. Young SN. Behavioral effects of dietary neurotransmitter precursors: basic and clinical aspects. Neùrosci Biobehav Rev 1996;20:313-323.
6. Owens MJ. Molecular and cellular mechanisms of antidepressant drugs. Depress Anxiety 1996;4:153-159.
7. Brunello N, Musselman D, Nemeroff C. Critical issues in the treatment of affective disorders. Depression 1995;3:187-189.
8. Duman RS, Heninger GR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997;54:597-606.
9. Dunlop SR, Dorsnief BE, Wernicke JF, Potvin JH. Pattern analysis shows beneficial effect of fluoxetine treatment in mild depression. Psychopharmacology Bull 1990;26:173-180.
10. Quitkin FM. Placebos, drug effects, and study design: a clinician's guide. Am J Psychiatry 1999;156:829-836.
11. Birdsall TC. 5-hydroxytryptophan: a clinically-effective serotonin precursor. Altern Med Rev 1998;3:271-280.
12. van Praag HM, Korf J, Dois LC, Schut T. A pilot study of the predictive value of the probenecid test in application of 5-hydroxytryptophan as antidepressant. Psychopharmacologia 1972;25:14-21.
13. van Praag HM. Central monamine metabolism in depression. II. Comp Psychiat 1980;21:44-54.
14. van Praag HM. Management of depression with serotonin precursors. Biol Psychiatry 1981;16:291-310.
15. Sano I. L-5-hydroxytryptophan (L-5-HTP) therapy. Folia Psychiatr Neurol Jpn 1972;26:7-17.
16. Takahashi S, Kondo H, Kato N. Effect of L-5-hydroxytryptophan on brain monoamine metabolism and evaluation of its clinical effect in depressed patients. J Psychiatr Res 1975;12:177-187.
17. Nakajima T, Kudo Y, Kaneko Z. Clinical evaluation of 5-hydroxy-L-tryptophan as an antidepressant drug. Folia Psychiatr Neurol Jpn 1978;32:223-230.
18. Kaneko M, Kumashiro H, Takahashi Y, Hoshino Y. L-5HTP treatment and serum 5-HT level after L-5-HTP loading on depressed patients. Neuropsychobiology 1979,5:232-240.
19. Angst J, Woggon B, Schoepf J. The treatment of depression with L-5-hydroxytryptophan versus imipramine. Results of two open and one double-blind study. Arch Psychiatr Nervenkr 1977;224:175-186.
20. Nolen WA, van de Putte JJ, Dijken WA, Kamp JS. L-5HTP in depression resistant to reuptake inhibitors. An open comparative study with tranylcypromine. Br J Psychiatry 1985;147:16-22.
21. Zmilacher K, Battegay R, Gastpar M. L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression. Neuropsychobiology 1988;20:28-35.
22. Poldinger W, Calanchini B, Schwarz W. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine. Psychopathology 1991;24:53-81.
23. Thomson J, Rankin H, Ashcroft GW, et al. The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychol Med 1982;12:741-751.
24. d'Elia G, Hanson L, Raotma H. L-tryptophan and 5-hydroxytryptophan in the treatment of depression. A review. Acta Psychiatrica Scandinavica 1978;57:239-252.
25. Beckmann H, Kasper S. Serotonin precursors as antidepressive agents: a review. Fortschr Neurol Psychiatr 1983;51:176-182. [Article in German]
26. Byerley WF, Judd LL, Reimherr FW, Grosser BI. 5-Hydroxytryptophan: a review of its antidepressant efficacy and adverse effects. J Clin Psychopharmacol 1987;7:127-137.
27. Gelenberg AJ, Wojcik JD, Growdon JH, et al. Tyrosine for the treatment of depression. Am J Psychiatry 1980;137:622-623.
28. Goldberg IK. L-tyrosine in depression. Lancet 1980;2:364-365.
29. Gelenberg AJ, Wojcik JD, Falk WE, et al. Tyrosine for depression: a double-blind trial. J Affect Disord 1990;19:125-132.
30. Beckmann H, Athen D, Olteanu M, Zimmer R. DL-phenylalanine versus imipramine: a double-blind controlled study. Arch Psychiatr Nervenkr 1979;227:49-58.
31. Mann J, Peselow ED, Snyderman S, Gershon S. D-phenylalanine in endogenous depression. Am J Psychiatr̀y 1980;137:1611-1612.
32. Sabelli HC, Fawcett J, Gusovsky F, et al. Clinical studies on the phenylethylamine hypothesis of affective disorder. J Clin Psychiatry 1986;47:66-70.
33. Lucini V, Lucca A, Catalano M, Smeraldi E. Predictive value of tryptophan/large neutral amino acids ratio to antidepressant response. J Affect Disord 1996;36:129-133.
34. Lucca A, Lucini V, Catalano M, et al. Plasma tryptophan to large neutral amino acids ratio and therapeutic response to a selective serotonin uptake inhibitor. Neuropsychobiology 1994;29:108-111.
35. Azorin JM, Bovier P, Widmer J, et al. L-tyrosine and L-tryptophan membrane transport in erythrocytes and antidepressant drug choice. Biol Psychiatry 1990;27:723-734.
36. Steiner W, Fontaine R. Toxic reaction following the combined administration of fluoxetine and L-tryptophan: five case reports. Biol Psychiatry 1986;21:1067-1071.
37. van Praag HM. In search of the mode of action of antidepressants: 5-HTP/tyrosine mixtures in depression. Adv Biochem Psychopharmacol 1984;39:301-314.